AC
Aquilo Capital Management, LLC Other
US US · SEC (Form 4)
€25m
▲ Purchases (29 ops.)
Discover the full record of transactions filed by Aquilo Capital Management, LLC. Officer active across 1 companies, notably Spero Therapeutics, Inc.. In total, 29 filings have been recorded. Total volume traded: €25.4m. The latest transaction was filed on 26 April 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations 29 total
€195,395 39,727 shares @ €4.9184 0.15% mcap 0.8% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000015:0 · 26 Apr 2022
Ideal exit: 21 Jan 2023 (T+270) €260,735 33,115 shares @ €7.8736 0.20% mcap 1.0% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000014:0 · 30 Mar 2022
Ideal exit: 25 Dec 2022 (T+270) €109,534 15,702 shares @ €6.9758 0.083% mcap 0.4% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000013:0 · 14 Mar 2022
Ideal exit: 9 Dec 2022 (T+270) €253,372 29,729 shares @ €8.5227 0.19% mcap 1.0% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000011:0 · 28 Feb 2022
Ideal exit: 25 Nov 2022 (T+270) €120,564 14,828 shares @ €8.1308 0.092% mcap 0.5% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000010:0 · 18 Feb 2022
Ideal exit: 15 Nov 2022 (T+270) €1m 125,000 shares @ €10.3889 0.99% mcap 10.6% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000004 · 31 Jan 2022
Ideal exit: 28 Oct 2022 (T+270) €1m 125,000 shares @ €10.3889 0.99% mcap 5.1% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000004:0 · 31 Jan 2022
Ideal exit: 28 Oct 2022 (T+270) €15,358 1,599 shares @ €9.6047 0.012% mcap 0.1% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000003 · 24 Jan 2022
Ideal exit: 21 Oct 2022 (T+270) €15,358 1,599 shares @ €9.6047 0.012% mcap 0.1% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000003:0 · 24 Jan 2022
Ideal exit: 21 Oct 2022 (T+270) €527,549 48,488 shares @ €10.88 0.40% mcap 4.3% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000002 · 18 Jan 2022
Ideal exit: 15 Oct 2022 (T+270) €527,549 48,488 shares @ €10.88 0.40% mcap 2.1% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000002:0 · 18 Jan 2022
Ideal exit: 15 Oct 2022 (T+270) €100,942 8,867 shares @ €11.384 0.077% mcap 0.8% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000001 · 10 Jan 2022
Ideal exit: 7 Oct 2022 (T+270) €100,942 8,867 shares @ €11.384 0.077% mcap 0.4% of flow
Common Stock, $0.001 par value
SEC:0001591986-22-000001:0 · 10 Jan 2022
Ideal exit: 7 Oct 2022 (T+270) €976,831 75,493 shares @ €12.9394 0.74% mcap 8.0% of flow
Common Stock, $0.001 par value
SEC:0001691902-22-000001 · 29 Dec 2021
Ideal exit: 25 Sept 2022 (T+270) €976,831 75,493 shares @ €12.9394 0.74% mcap 3.8% of flow
Common Stock, $0.001 par value
SEC:0001691902-22-000001:0 · 29 Dec 2021
Ideal exit: 25 Sept 2022 (T+270) €2m 150,000 shares @ €15.0078 1.71% mcap 18.4% of flow
Common Stock, $0.001 par value
SEC:0001591986-21-000016 · 29 Oct 2021
Ideal exit: 26 Jul 2022 (T+270) €2m 150,000 shares @ €15.0078 1.71% mcap 8.9% of flow
Common Stock, $0.001 par value
SEC:0001591986-21-000016:0 · 29 Oct 2021
Ideal exit: 26 Jul 2022 (T+270) €2m 134,543 shares @ €16.1127 1.65% mcap 17.7% of flow
Common Stock, $0.001 par value
SEC:0001591986-21-000015 · 30 Sept 2021
Ideal exit: 27 Jun 2022 (T+270) €2m 134,543 shares @ €16.1127 1.65% mcap 8.5% of flow
Common Stock, $0.001 par value
SEC:0001591986-21-000015:0 · 30 Sept 2021
Ideal exit: 27 Jun 2022 (T+270) €694,783 44,210 shares @ €15.7155 0.53% mcap 5.7% of flow
Common Stock, $0.001 par value
SEC:0001591986-21-000014 · 13 Sept 2021
Ideal exit: 10 Jun 2022 (T+270) €694,783 44,210 shares @ €15.7155 0.53% mcap 2.7% of flow
Common Stock, $0.001 par value
SEC:0001591986-21-000014:0 · 13 Sept 2021
Ideal exit: 10 Jun 2022 (T+270) €387,109 24,749 shares @ €15.6414 0.29% mcap 3.2% of flow
Common Stock, $0.001 par value
SEC:0001591986-21-000013 · 9 Sept 2021
Ideal exit: 6 Jun 2022 (T+270) €387,109 24,749 shares @ €15.6414 0.29% mcap 1.5% of flow
Common Stock, $0.001 par value
SEC:0001591986-21-000013:0 · 9 Sept 2021
Ideal exit: 6 Jun 2022 (T+270) €667,004 44,042 shares @ €15.1447 0.51% mcap 5.5% of flow
Common Stock, $0.001 par value
SEC:0001591986-21-000012 · 30 Aug 2021
Ideal exit: 27 May 2022 (T+270) €667,004 44,042 shares @ €15.1447 0.51% mcap 2.6% of flow
Common Stock, $0.001 par value
SEC:0001591986-21-000012:0 · 30 Aug 2021
Ideal exit: 27 May 2022 (T+270) 25 of 29 declarations
Load more (4 remaining) About Aquilo Capital Management, LLC Aquilo Capital Management, LLC is a significant shareholder of Spero Therapeutics, Inc.